Published in Proc Natl Acad Sci U S A on November 01, 1971
A comparative evaluation of the distribution of concanavalin A-binding sites on the surfaces of normal, virally-transformed, and protease-treated fibroblasts. Proc Natl Acad Sci U S A (1973) 2.88
Differences in the binding of fluorescent concanavalin A to the surface membrane of normal and transformed cells. Proc Natl Acad Sci U S A (1972) 1.20
The biochemistry of virus-induced cell fusion. Changes in membrane integrity. Biochem J (1974) 1.11
Membrane changes and adenosine triphosphate content in normal and malignant transformed cells. Proc Natl Acad Sci U S A (1973) 1.11
Galactosyltransferase and concanavalin A agglutination of cells. Proc Natl Acad Sci U S A (1974) 1.11
Cyclic AMP mediates the concanavalin A agglutinability of mouse fibroblasts. J Cell Biol (1974) 0.89
The undifferentiated and extended forms of C1300 murine neuroblastoma. An ultrastructural study and detection of concanavalin A binding sites on the plasma membrane. Am J Pathol (1974) 0.86
Colchicine affects kinetics of concanavalin a-mediated agglutination of hepatoma cells and plasma membranes from liver and hepatoma cells. Proc Natl Acad Sci U S A (1975) 0.77
Ligand-induced redistribution of membrane macromolecules: some possible implications for cancer. J Clin Pathol Suppl (R Coll Pathol) (1974) 0.75
Changes in concanavalin A-mediated agglutination of hormone-dependent mouse mammary tumour cells during serial transplantation. Br J Cancer (1980) 0.75
Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO. Proc Natl Acad Sci U S A (1962) 14.59
PROTEIN-CARBOHYDRATE INTERACTION. II. INHIBITION STUDIES ON THE INTERACTION OF CONCANAVALIN A WITH POLYSACCHARIDES. Biochemistry (1965) 6.56
Identification of Hemagglutinin of Jack Bean with Concanavalin A. J Bacteriol (1936) 6.29
A difference in the architecture of the surface membrane of normal and virally transformed cells. Proc Natl Acad Sci U S A (1969) 6.03
Interaction of the carbohydrate-binding protein concanavalin A with normal and transformed cells. Proc Natl Acad Sci U S A (1969) 5.39
Structural difference in sites on the surface membrane of normal and transformed cells. Nature (1969) 3.81
ANTIGENIC PROPERTIES OF LYMPHOMAS INDUCED BY THE MOLONEY AGENT. J Natl Cancer Inst (1964) 3.36
Unusual fragments in the subunit structure of concanavalin A. Proc Natl Acad Sci U S A (1971) 2.62
Specific inhibition by N-acetyl-D-galactosamine of the interaction between soybean agglutinin and animal cell surfaces. Biochim Biophys Acta (1970) 2.33
The interaction of concanavalin A with methyl alpha-D-glucopyranoside. Biochim Biophys Acta (1968) 2.09
Antigenic and cultural properties of cells doubly transformed by polyoma virus and SV40. Virology (1965) 1.74
Differential toxicity on normal and transformed cells in vitro and inhibition of tumour development in vivo by concanavalin A. Nature (1970) 1.64
The in vitro induction of an increase in cell multiplication and cellular life span by the water-soluble carcinogen dimethylnitrosamine. Proc Natl Acad Sci U S A (1968) 1.60
Ciromosomal control of reversion in transformed cells. Nature (1971) 1.48
The formation of variants with a reversion of properties of transformed cells. 3. Reversion of the structure of the cell surface membrane. Int J Cancer (1969) 1.17
Requirement for cell replication after SV40 infection for a structural change of the cell surface membrane. Virology (1970) 1.02
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (1991) 9.21
The cloning of normal "mast" cells in tissue culture. J Cell Physiol (1965) 5.47
Interaction of the carbohydrate-binding protein concanavalin A with normal and transformed cells. Proc Natl Acad Sci U S A (1969) 5.39
Characterization of the simian virus 40-specific RNA in virus-yielding and transformed cells. J Mol Biol (1968) 4.65
The induction of cellular DNA synthesis by simian virus 40 in contact-inhibited and in x-irradiated cells. Proc Natl Acad Sci U S A (1966) 4.64
In vitro transformation of normal cells to tumor cells by carcinogenic hydrocarbons. J Natl Cancer Inst (1965) 4.53
In vitro control of the development of macrophage and granulocyte colonies. Proc Natl Acad Sci U S A (1966) 4.13
Structural difference in sites on the surface membrane of normal and transformed cells. Nature (1969) 3.81
The induction of clones of normal mast cells by a substance from conditioned medium. Exp Cell Res (1966) 3.01
Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature (1978) 2.97
Microviscosity parameters and protein mobility in biological membranes. Biochim Biophys Acta (1976) 2.95
In vitro cell transformation by x-irradiation. Nature (1966) 2.75
Induction of colony formation in vitro by human lymphocytes. Nature (1976) 2.71
On the mechanism of polyoma virus-induced synthesis of cellular DNA. Proc Natl Acad Sci U S A (1965) 2.67
Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Int J Cancer (1977) 2.66
Difference in microviscosity induced by different cholesterol levels in the surface membrane lipid layer of normal lymphocytes and malignant lymphoma cells. J Mol Biol (1974) 2.48
Destruction of mouse and rat embryo cells in tissue culture by lymph node cells from unsensitized rats. J Cell Physiol (1965) 2.44
Specific inhibition by N-acetyl-D-galactosamine of the interaction between soybean agglutinin and animal cell surfaces. Biochim Biophys Acta (1970) 2.33
Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci U S A (1990) 2.25
In vitro induction of granulocyte differentiation in hematopoietic cells from leukemic and non-leukemic patients. Proc Natl Acad Sci U S A (1970) 2.22
Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion. Proc Natl Acad Sci U S A (1979) 2.17
Cervical competence as a continuum: a study of ultrasonographic cervical length and obstetric performance. Am J Obstet Gynecol (1995) 2.10
Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc Natl Acad Sci U S A (2001) 2.10
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Cancer (1976) 1.97
Identification of mutagenic metabolites of benzo(a)pyrene in mammalian cells. Proc Natl Acad Sci U S A (1976) 1.96
Hybridization between SV40 DNA and cellular DNA's. J Mol Biol (1969) 1.92
Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood (1993) 1.90
Cell susceptibility to transformation and cytotoxicity by the carcinogenic hydrocarbon benzo[a]pyrene. Proc Natl Acad Sci U S A (1966) 1.86
Control of lysozyme induction in the differentiation of myeloid leukemic cells. Cell (1976) 1.79
Reversion of properties in cells transformed by polyoma virus. Nature (1968) 1.79
DNA rearrangement of a homeobox gene in myeloid leukaemic cells. EMBO J (1988) 1.75
Biotype-dependent secondary symbiont communities in sympatric populations of Bemisia tabaci. Bull Entomol Res (2007) 1.72
The continued requirement for inducer for the development of macrophage and granulocyte colonies. J Cell Physiol (1968) 1.67
Receptor mobility and the mechanism of cell-cell binding induced by concanavalin A. Proc Natl Acad Sci U S A (1974) 1.65
An analysis of the mechanism of neoplastic cell transformation by polyoma virus, hydrocarbons, and x-irradiation. Curr Top Dev Biol (1967) 1.64
Differential toxicity on normal and transformed cells in vitro and inhibition of tumour development in vivo by concanavalin A. Nature (1970) 1.64
Chromosome mapping of the genes that control differentiation and malignancy in myeloid leukemic cells. Proc Natl Acad Sci U S A (1977) 1.64
The in vitro induction of an increase in cell multiplication and cellular life span by the water-soluble carcinogen dimethylnitrosamine. Proc Natl Acad Sci U S A (1968) 1.60
The difference in contact inhibition of cell replication between normal cells and cells transformed by different carcinogens. Proc Natl Acad Sci U S A (1966) 1.59
Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth Differ (1993) 1.50
Ciromosomal control of reversion in transformed cells. Nature (1971) 1.48
Mutability of different genetic loci in mammalian cells by metabolically activated carcinogenic polycyclic hydrocarbons. Proc Natl Acad Sci U S A (1976) 1.47
Different blocks in the differentiation of myeloid leukemic cells. Proc Natl Acad Sci U S A (1974) 1.47
The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6. Blood (1988) 1.47
A theory on the mechanism of carcinogenesis by small deoxyribonucleic acid tumour viruses. Nature (1965) 1.45
Control of the reversion of properties in transformed cells. Nature (1970) 1.44
Control of normal differentiation of myeloid leukemic cells. VIII. Induction of differentiation to mature granulocytes in mass culture. J Cell Physiol (1975) 1.42
Cell susceptibility to transformation by x-irradiation and fixation of the transformed state. Proc Natl Acad Sci U S A (1967) 1.41
Rotational relaxation time of concanavalin A bound to the surface membrane of normal and malignant transformed cells. J Mol Biol (1973) 1.40
Mobility of carbohydrate containing sites on the surface membrane in relation to the control of cell growth. FEBS Lett (1973) 1.39
Regulation of membrane changes, differentiation, and malignancy in carcinogenesis. Harvey Lect (1974) 1.39
[CFS, the condition with the thousands different names. "The tired nomad"--a modern epidemic?]. Lakartidningen (1994) 1.38
Ion metabolism in a Halobacterium. I. Influence of age of culture on intracellular concentrations. J Gen Physiol (1970) 1.38
Mutagenesis and transformation of normal cells by chemical carcinogens. Nature (1976) 1.37
Inhibition of ascites tumor development by concanavalin A. Int J Cancer (1972) 1.36
Control of normal differentiation of myeloid leukemic cells to macrophages and granulocytes. Proc Natl Acad Sci U S A (1973) 1.36
Constitutive uncoupling of pathways of gene expression that control growth and differentiation in myeloid leukemia: a model for the origin and progression of malignancy. Proc Natl Acad Sci U S A (1980) 1.35
Induction of virus synthesis in polyoma transformed cells by ultraviolet light and mitomycin C. Virology (1970) 1.34
Enzymatic hydroxylation of benzopyrene and its relationship to cytotoxicity. Proc Natl Acad Sci U S A (1969) 1.33
Cell-mediated mutagenesis of mammalian cells with chemical carcinogens. Int J Cancer (1974) 1.32
Genetic dissection of the control of normal differentiation in myeloid leukemic cells. Proc Natl Acad Sci U S A (1977) 1.32
The stimulation of tumor cell growth by a substance produced by normal and tumor cells. J Cell Physiol (1969) 1.30
Increase of cholesterol level in the surface membrane of lymphoma cells and its inhibitory effect on ascites tumor development. Proc Natl Acad Sci U S A (1974) 1.30
Formation of bone tissue in culture from isolated bone cells. J Cell Biol (1974) 1.30
The activation of virus synthesis in polyoma-transformed cells. Virology (1969) 1.28
Induction of specific changes in the surface membrane of myeloid leukemic cells by steroid hormones. Int J Cancer (1975) 1.28
Receptor mobility and the binding of cells to lectin-coated fibers. J Cell Biol (1975) 1.27
Papovaviridae. Intervirology (1974) 1.26
Regulation of the induction of colonies in vitro by normal human lymphocytes. Proc Natl Acad Sci U S A (1976) 1.24
The oncogenic potential of an activated Hox-2.4 homeobox gene in mouse fibroblasts. Mol Cell Biol (1991) 1.23
Indirect induction of differentiation in myeloid leukemic cells by lipid A. Proc Natl Acad Sci U S A (1978) 1.23
Identification of the chromosomes that control malignancy. Nat New Biol (1973) 1.22
Multiple primary malignancies in association with soft tissue sarcomas. Cancer (2001) 1.21
Control of Fc and C3 receptors on myeloid leukemic cells. J Immunol (1976) 1.20
Decreased prevalence of asymptomatic choroidal metastasis in disseminated breast and lung cancer: argument against screening. Br J Ophthalmol (2006) 1.20
Differences in the binding of fluorescent concanavalin A to the surface membrane of normal and transformed cells. Proc Natl Acad Sci U S A (1972) 1.20
Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment. Eur J Cancer (2004) 1.19
Characterization of the inducer required for the development of macrophage and granulocyte colonies. Proc Natl Acad Sci U S A (1971) 1.19
Familial hyperinsulinism maps to chromosome 11p14-15.1, 30 cM centromeric to the insulin gene. Nat Genet (1994) 1.18
Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway. EMBO J (2000) 1.18
Integration of viral into chromosomal deoxyribonucleic acid in an inducible line of polyoma-transformed cells. Virology (1973) 1.17
The diagnosis of sex before birth using cells from the amniotic fluid (a preliminary report). Bull Res Counc Isr (1955) 1.17
The formation of variants with a reversion of properties of transformed cells. 3. Reversion of the structure of the cell surface membrane. Int J Cancer (1969) 1.17
Enzymatic hydrolysis of uridine diphosphate-N-acetyl-D-galactosamine and uridine diphosphate-N-acetyl-D-glucosamine by normal cells, and blocks in this hydrolysis in transformed cells and their revertants. J Biol Chem (1972) 1.16
The meaning of 6.8: numeracy and normality in health information talks. Soc Sci Med (1996) 1.16
Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood (1992) 1.16
Cholesterol as a bioregulator in the development and inhibition of leukemia. Proc Natl Acad Sci U S A (1974) 1.15
Feedback inhibition of the development of macrophage and granulocyte colonies. I. Inhibition by macrophage. Proc Natl Acad Sci U S A (1967) 1.15
Normal differentiation of myeloid leukaemic cells induced by a differentiation-inducing protein. Nat New Biol (1972) 1.15
Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study. Cancer Chemother Pharmacol (2000) 1.15
Membrane changes associated with malignancy. Nat New Biol (1972) 1.14